Key Reasons BTIG Just Upgraded Kite Pharma

By: via Benzinga
A solid strategy and great execution have led BTIG analyst, Dane Leone, to upgrade his recommendation on Kite Pharma Inc. (NASDAQ: KITE) ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.